Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Johnson and Johnson
Colorcon
Chinese Patent Office
Express Scripts
Daiichi Sankyo
McKinsey
AstraZeneca
Boehringer Ingelheim
Teva

Generated: January 18, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,887,836

« Back to Dashboard

Summary for Patent: 7,887,836
Title:Compositions and methods for treating lymphoma
Abstract: This invention provides methods for treating neoplasias in a mammal. In particular, the invention provides methods for treating various types of lymphomas, including relapsed forms of non-Hodgkin's Lymphoma. These methods involve the administration of liposome-encapsulated vinca alkaloids, e.g., vincristine, to a mammal with a lymphoma.
Inventor(s): Sarris; Andreas H. (Athens, GR), Cabanillas; Fernando (San Juan, PR), Logan; Patricia M. (Grand Forks, CA), Burge; Clive T. R. (Brentwood Bay, CA), Goldie; James H. (Vancouver, CA), Webb; Murray S. (N. Vancouver, CA)
Assignee: Hana Biosciences, Inc. (South San Francisco, CA) Board of Regents, The University of Texas System (Austin, TX)
Application Number:12/075,013
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form; Formulation;

Drugs Protected by US Patent 7,887,836

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Talon Therap MARQIBO KIT vincristine sulfate INJECTABLE, LIPOSOMAL;INTRAVENOUS 202497-001 Aug 9, 2012 RX Yes Yes ➤ Subscribe ➤ Subscribe TREATMENT OF ADULT PATIENTS WITH PHILADELPHIA CHROMOSOME-NEGATIVE(PH-) ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) IN SECOND OR GREATER RELAPSE OR WHOSE DISEASE HAS PROGRESSED FOLLOWING TWO OR MOR ANTI-LEUKEMIA THERAPIES ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 7,887,836

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,247,316 Compositions and methods for treating lymphoma ➤ Subscribe
6,723,338 Compositions and methods for treating lymphoma ➤ Subscribe
7,060,828 Liposomal camptothecins and uses thereof ➤ Subscribe
7,311,924 Compositions and methods for treating cancer ➤ Subscribe
7,244,450 Compositions and methods for treating lymphoma ➤ Subscribe
7,244,448 Liposomal antineoplastic drugs and uses thereof ➤ Subscribe
7,452,550 Liposomal antineoplastic drugs and uses thereof ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 7,887,836

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 309786 ➤ Subscribe
Austria 309787 ➤ Subscribe
Austria 442839 ➤ Subscribe
Australia 2001270385 ➤ Subscribe
Australia 4060600 ➤ Subscribe
Australia 7038501 ➤ Subscribe
Australia 7041301 ➤ Subscribe
Australia 777572 ➤ Subscribe
Brazil 0009448 ➤ Subscribe
Canada 2366787 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Chinese Patent Office
Express Scripts
Argus Health
Moodys
Queensland Health
Mallinckrodt
Medtronic
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot